Tesamorelin 10mg
This growth hormone releasing hormone analog has demonstrated specific efficacy in reducing visceral adipose tissue in HIV-associated lipodystrophy. Research has shown average reductions in visceral fat of 15-20% while preserving subcutaneous fat and muscle mass. Studies have documented improvements in cardiovascular risk markers, liver fat content, and cognitive function in treated patients. The peptide has gained FDA approval for lipodystrophy and recognition for its potential in treating metabolic dysfunction and age-related cognitive decline.
This growth hormone releasing hormone analog has demonstrated specific efficacy in reducing visceral adipose tissue in HIV-associated lipodystrophy. Research has shown average reductions in visceral fat of 15-20% while preserving subcutaneous fat and muscle mass. Studies have documented improvements in cardiovascular risk markers, liver fat content, and cognitive function in treated patients. The peptide has gained FDA approval for lipodystrophy and recognition for its potential in treating metabolic dysfunction and age-related cognitive decline.
Purity: ≥99% Purity · Formula: C221H366N72O67S · CAS: 218949-48-5
Fulfilled and shipped direct by MedFit. Orders are confirmed by email, and we follow up on protocol questions ourselves — call the studio any time.